Dow Jones

43 449,90

-0,61%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

SCYX

Scynexis (SCYX)

Scynexis Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SCYX

1 2 3 4 5 6 7 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
15/11/2024	01h07	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SCYX	Scynexis Inc
06/11/2024	22h10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SCYX	Scynexis Inc
06/11/2024	22h06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:SCYX	Scynexis Inc
06/11/2024	22h01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SCYX	Scynexis Inc
16/09/2024	14h00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SCYX	Scynexis Inc
20/06/2024	14h01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SCYX	Scynexis Inc
14/02/2024	03h09	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SCYX	Scynexis Inc
28/11/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SCYX	Scynexis Inc
13/11/2023	23h09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:SCYX	Scynexis Inc
28/09/2023	02h31	GlobeNewswire Inc.	SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) due to potential for cross contamination with a non-antibacterial ß-lactam drug substance	NASDAQ:SCYX	Scynexis Inc
23/06/2023	22h18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SCYX	Scynexis Inc
23/06/2023	22h02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCYX	Scynexis Inc
09/06/2023	22h30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SCYX	Scynexis Inc
01/05/2023	22h18	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:SCYX	Scynexis Inc
01/05/2023	22h07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SCYX	Scynexis Inc
01/05/2023	22h06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SCYX	Scynexis Inc
03/04/2023	14h12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SCYX	Scynexis Inc
31/03/2023	13h25	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SCYX	Scynexis Inc
31/03/2023	13h17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SCYX	Scynexis Inc
30/03/2023	16h43	Dow Jones News	Scynexis Shares Jump 60% After Licensing Deal With GSK	NASDAQ:SCYX	Scynexis Inc
02/12/2022	19h15	TipRanks	Maxim Group Remains a Buy on SCYNEXIS (SCYX)	NASDAQ:SCYX	Scynexis Inc
02/12/2022	12h45	TipRanks	SCYNEXIS (SCYX) Receives a Buy from Ladenburg Thalmann & Co.	NASDAQ:SCYX	Scynexis Inc
10/11/2022	18h20	TipRanks	Analysts’ Top Healthcare Picks: Larimar Therapeutics (LRMR), SCYNEXIS (SCYX)	NASDAQ:SCYX	Scynexis Inc
10/11/2022	12h45	TipRanks	Ladenburg Thalmann & Co. Reaffirms Their Buy Rating on SCYNEXIS (SCYX)	NASDAQ:SCYX	Scynexis Inc
26/10/2022	22h08	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SCYX	Scynexis Inc
26/10/2022	21h41	TipRanks	Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), SCYNEXIS (SCYX) and Karuna Therapeutics (KRTX)	NASDAQ:SCYX	Scynexis Inc
16/08/2022	19h40	TipRanks	Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Clene (CLNN)	NASDAQ:SCYX	Scynexis Inc
16/08/2022	12h05	TipRanks	H.C. Wainwright Remains a Buy on SCYNEXIS (SCYX)	NASDAQ:SCYX	Scynexis Inc
16/08/2022	03h05	TipRanks	Brookline Capital Markets Keeps Their Buy Rating on SCYNEXIS (SCYX)	NASDAQ:SCYX	Scynexis Inc
15/08/2022	22h08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SCYX	Scynexis Inc